Francesco Pepe

2.7k total citations
108 papers, 1.5k citations indexed

About

Francesco Pepe is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Francesco Pepe has authored 108 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 59 papers in Cancer Research and 57 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Francesco Pepe's work include Cancer Genomics and Diagnostics (56 papers), Lung Cancer Treatments and Mutations (49 papers) and Colorectal Cancer Treatments and Studies (24 papers). Francesco Pepe is often cited by papers focused on Cancer Genomics and Diagnostics (56 papers), Lung Cancer Treatments and Mutations (49 papers) and Colorectal Cancer Treatments and Studies (24 papers). Francesco Pepe collaborates with scholars based in Italy, United States and Spain. Francesco Pepe's co-authors include Umberto Malapelle, Giancarlo Troncone, Pasquale Pisapia, Gianluca Russo, Claudio Bellevicine, Caterina De Luca, Roberta Sgariglia, Christian Rolfo, Valerio Gristina and Mariantonia Nacchio and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Francesco Pepe

102 papers receiving 1.5k citations

Peers

Francesco Pepe
Alvin Wong Singapore
Alexey Aleshin United States
Zoya Kingsbury United Kingdom
Patricia Vasalos United States
Luc Cabel France
Petros Nikolinakos United States
Sabrina Rajan United Kingdom
Heather Biggs United Kingdom
Gillian Ellison United Kingdom
Alvin Wong Singapore
Francesco Pepe
Citations per year, relative to Francesco Pepe Francesco Pepe (= 1×) peers Alvin Wong

Countries citing papers authored by Francesco Pepe

Since Specialization
Citations

This map shows the geographic impact of Francesco Pepe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Pepe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Pepe more than expected).

Fields of papers citing papers by Francesco Pepe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Pepe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Pepe. The network helps show where Francesco Pepe may publish in the future.

Co-authorship network of co-authors of Francesco Pepe

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Pepe. A scholar is included among the top collaborators of Francesco Pepe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Pepe. Francesco Pepe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Venetis, Konstantinos, Francesco Pepe, Omshree Shetty, et al.. (2025). International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors. PubMed. 8. 100301–100301. 7 indexed citations
2.
Buglioni, Simonetta, Fabio Pagni, Nicola Fusco, et al.. (2025). Part III – Post-analytical phase. Pathologica. 117(2). 36–36. 1 indexed citations
3.
Corte, Luigi Della, Gianluca Russo, Francesco Pepe, et al.. (2024). The role of liquid biopsy in epithelial ovarian cancer: State of the art. Critical Reviews in Oncology/Hematology. 194. 104263–104263. 6 indexed citations
4.
Pepe, Francesco, et al.. (2024). Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path?. Critical Reviews in Oncology/Hematology. 197. 104332–104332. 8 indexed citations
5.
Pisapia, Pasquale, Alessandro Russo, Caterina De Luca, et al.. (2024). The relevance of the reference range for EGFR testing in non-small cell lung cancer patients. Lung Cancer. 198. 108002–108002. 3 indexed citations
6.
Capezzone, Marco, Elisabetta Macerola, Silvia Cantara, et al.. (2024). Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer. SHILAP Revista de lepidopterología. 2024. 1–5. 2 indexed citations
7.
Pepe, Francesco, Gianluca Russo, Umberto Malapelle, et al.. (2024). The Impact of potential ‘confounders’ on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study. Journal of Clinical Pathology. 77(8). 557–560. 1 indexed citations
8.
L’Imperio, Vincenzo, Carla Rossana Scalia, Gianluca Gragnano, et al.. (2024). Economic assessment of NGS testing workflow for NSCLC in a healthcare setting. Heliyon. 10(7). e29272–e29272.
9.
Malapelle, Umberto, Francesco Passiglia, Francesco Pepe, et al.. (2024). The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database. Lung Cancer. 191. 107787–107787. 2 indexed citations
10.
Pepe, Francesco, Claudia Giordano, Gianluca Russo, et al.. (2023). Liquid biopsy: A promising tool for driving strategies and predicting failures in patients with classic Hodgkin lymphoma. Cytopathology. 35(2). 182–187. 2 indexed citations
11.
Malapelle, Umberto, Fabio Pagni, Filippo Fraggetta, et al.. (2023). Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group. Critical Reviews in Oncology/Hematology. 193. 104217–104217. 7 indexed citations
12.
Bessi, Silvia, et al.. (2023). ERBB2 VARIANTS DISTRIBUTION IN NON-SMALL CELL LUNG CANCER: AN ITALIAN REAL-WORLD EXPERIENCE. 3(2). 99–99. 1 indexed citations
13.
Mangogna, Alessandro, Giada Munari, Francesco Pepe, et al.. (2023). Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches. Journal of Personalized Medicine. 13(2). 284–284. 21 indexed citations
14.
Ferraro, Angelo, A.C. Cefalas, Z. Kollia, et al.. (2023). Nanoscale Prognosis of Colorectal Cancer Metastasis from AFM Image Processing of Histological Sections. Cancers. 15(4). 1220–1220. 5 indexed citations
15.
Sahnane, Nora, Francesco Pepe, Pasquale Pisapia, et al.. (2022). Critical aspects of microsatellite instability testing in endometrial cancer: a comparison study. Human Pathology. 128. 134–140. 12 indexed citations
16.
Parente, Paola, Umberto Malapelle, Valentina Angerilli, et al.. (2022). MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice. Journal of Clinical Pathology. 76(7). 492–496. 8 indexed citations
17.
Felice, Marco De, Pasquale Pisapia, Francesco Pepe, et al.. (2022). Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature. Applied Sciences. 12(15). 7552–7552. 1 indexed citations
18.
Crocetto, Felice, Gianluca Russo, Erika Di Zazzo, et al.. (2022). Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives. Cancers. 14(13). 3272–3272. 74 indexed citations
19.
Malapelle, Umberto, Sara Pilotto, Maria Lucia Reale, et al.. (2021). Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients. Critical Reviews in Oncology/Hematology. 169. 103536–103536. 11 indexed citations
20.
Bellevicine, Claudio, Roberta Sgariglia, Mariantonia Nacchio, et al.. (2021). Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective. SHILAP Revista de lepidopterología. 2(3). 233–240. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026